nodes	percent_of_prediction	percent_of_DWPC	metapath
Cephalexin—ALB—Vandetanib—thyroid cancer	0.259	0.477	CbGbCtD
Cephalexin—CYP3A4—Vandetanib—thyroid cancer	0.0812	0.15	CbGbCtD
Cephalexin—CYP2D6—Sorafenib—thyroid cancer	0.0769	0.142	CbGbCtD
Cephalexin—CYP3A4—Sorafenib—thyroid cancer	0.0489	0.0902	CbGbCtD
Cephalexin—CYP2D6—Doxorubicin—thyroid cancer	0.0467	0.0861	CbGbCtD
Cephalexin—CYP3A4—Doxorubicin—thyroid cancer	0.0297	0.0547	CbGbCtD
Cephalexin—Tubulointerstitial nephritis—Vandetanib—thyroid cancer	0.011	0.024	CcSEcCtD
Cephalexin—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.00963	0.021	CcSEcCtD
Cephalexin—Blood bilirubin increased—Vandetanib—thyroid cancer	0.00888	0.0194	CcSEcCtD
Cephalexin—Creatinine increased—Vandetanib—thyroid cancer	0.00882	0.0193	CcSEcCtD
Cephalexin—Colitis—Vandetanib—thyroid cancer	0.00806	0.0176	CcSEcCtD
Cephalexin—Tubulointerstitial nephritis—Sorafenib—thyroid cancer	0.00739	0.0162	CcSEcCtD
Cephalexin—Blood bilirubin increased—Sorafenib—thyroid cancer	0.00599	0.0131	CcSEcCtD
Cephalexin—Blood creatinine increased—Vandetanib—thyroid cancer	0.00571	0.0125	CcSEcCtD
Cephalexin—Gastritis—Vandetanib—thyroid cancer	0.00539	0.0118	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Vandetanib—thyroid cancer	0.00537	0.0117	CcSEcCtD
Cephalexin—Prothrombin level increased—Epirubicin—thyroid cancer	0.0051	0.0111	CcSEcCtD
Cephalexin—Neutropenia—Vandetanib—thyroid cancer	0.00492	0.0108	CcSEcCtD
Cephalexin—Prothrombin level increased—Doxorubicin—thyroid cancer	0.00472	0.0103	CcSEcCtD
Cephalexin—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0047	0.0103	CcSEcCtD
Cephalexin—Infestation NOS—Vandetanib—thyroid cancer	0.0047	0.0103	CcSEcCtD
Cephalexin—Infestation—Vandetanib—thyroid cancer	0.0047	0.0103	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00466	0.0102	CcSEcCtD
Cephalexin—Hepatobiliary disease—Vandetanib—thyroid cancer	0.00444	0.00971	CcSEcCtD
Cephalexin—Haemoglobin—Vandetanib—thyroid cancer	0.00424	0.00926	CcSEcCtD
Cephalexin—Haemorrhage—Vandetanib—thyroid cancer	0.00422	0.00921	CcSEcCtD
Cephalexin—Urinary tract disorder—Vandetanib—thyroid cancer	0.00416	0.0091	CcSEcCtD
Cephalexin—Urethral disorder—Vandetanib—thyroid cancer	0.00413	0.00903	CcSEcCtD
Cephalexin—Lactic dehydrogenase activity increased—Epirubicin—thyroid cancer	0.00409	0.00894	CcSEcCtD
Cephalexin—Erythema multiforme—Vandetanib—thyroid cancer	0.00399	0.00871	CcSEcCtD
Cephalexin—Anorectal discomfort—Epirubicin—thyroid cancer	0.00383	0.00837	CcSEcCtD
Cephalexin—Lactic dehydrogenase activity increased—Doxorubicin—thyroid cancer	0.00378	0.00827	CcSEcCtD
Cephalexin—Breast disorder—Sorafenib—thyroid cancer	0.00371	0.00812	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.0037	0.00809	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.0037	0.00809	CcSEcCtD
Cephalexin—Mental disorder—Vandetanib—thyroid cancer	0.00369	0.00807	CcSEcCtD
Cephalexin—Gastritis—Sorafenib—thyroid cancer	0.00364	0.00795	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Sorafenib—thyroid cancer	0.00363	0.00792	CcSEcCtD
Cephalexin—Blood lactate dehydrogenase increased—Epirubicin—thyroid cancer	0.0036	0.00787	CcSEcCtD
Cephalexin—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00354	0.00774	CcSEcCtD
Cephalexin—Vaginal discharge—Epirubicin—thyroid cancer	0.00344	0.00752	CcSEcCtD
Cephalexin—Blood lactate dehydrogenase increased—Doxorubicin—thyroid cancer	0.00333	0.00728	CcSEcCtD
Cephalexin—Neutropenia—Sorafenib—thyroid cancer	0.00332	0.00726	CcSEcCtD
Cephalexin—Vaginal discharge—Doxorubicin—thyroid cancer	0.00318	0.00696	CcSEcCtD
Cephalexin—Convulsion—Vandetanib—thyroid cancer	0.00318	0.00695	CcSEcCtD
Cephalexin—Infestation NOS—Sorafenib—thyroid cancer	0.00317	0.00692	CcSEcCtD
Cephalexin—Infestation—Sorafenib—thyroid cancer	0.00317	0.00692	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00314	0.00686	CcSEcCtD
Cephalexin—Arthralgia—Vandetanib—thyroid cancer	0.00312	0.00683	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0031	0.00678	CcSEcCtD
Cephalexin—Hepatobiliary disease—Sorafenib—thyroid cancer	0.003	0.00655	CcSEcCtD
Cephalexin—Nervous system disorder—Vandetanib—thyroid cancer	0.00294	0.00642	CcSEcCtD
Cephalexin—Thrombocytopenia—Vandetanib—thyroid cancer	0.00293	0.00641	CcSEcCtD
Cephalexin—Skin disorder—Vandetanib—thyroid cancer	0.00291	0.00636	CcSEcCtD
Cephalexin—Haemoglobin—Sorafenib—thyroid cancer	0.00286	0.00625	CcSEcCtD
Cephalexin—Haemorrhage—Sorafenib—thyroid cancer	0.00284	0.00621	CcSEcCtD
Cephalexin—Urinary tract disorder—Sorafenib—thyroid cancer	0.00281	0.00614	CcSEcCtD
Cephalexin—Connective tissue disorder—Sorafenib—thyroid cancer	0.00279	0.00611	CcSEcCtD
Cephalexin—Urethral disorder—Sorafenib—thyroid cancer	0.00279	0.00609	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00273	0.00596	CcSEcCtD
Cephalexin—Erythema multiforme—Sorafenib—thyroid cancer	0.00269	0.00588	CcSEcCtD
Cephalexin—Dyspepsia—Vandetanib—thyroid cancer	0.00264	0.00576	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00259	0.00565	CcSEcCtD
Cephalexin—Fatigue—Vandetanib—thyroid cancer	0.00258	0.00564	CcSEcCtD
Cephalexin—Immune system disorder—Sorafenib—thyroid cancer	0.00257	0.00561	CcSEcCtD
Cephalexin—Mental disorder—Sorafenib—thyroid cancer	0.00249	0.00544	CcSEcCtD
Cephalexin—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00245	0.00535	CcSEcCtD
Cephalexin—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00238	0.0052	CcSEcCtD
Cephalexin—Abdominal pain—Vandetanib—thyroid cancer	0.00237	0.00517	CcSEcCtD
Cephalexin—Body temperature increased—Vandetanib—thyroid cancer	0.00237	0.00517	CcSEcCtD
Cephalexin—Arthropathy—Epirubicin—thyroid cancer	0.0023	0.00503	CcSEcCtD
Cephalexin—Angioedema—Sorafenib—thyroid cancer	0.00226	0.00494	CcSEcCtD
Cephalexin—Leukopenia—Sorafenib—thyroid cancer	0.00222	0.00484	CcSEcCtD
Cephalexin—Blood bilirubin increased—Epirubicin—thyroid cancer	0.00221	0.00484	CcSEcCtD
Cephalexin—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.0022	0.00482	CcSEcCtD
Cephalexin—Creatinine increased—Epirubicin—thyroid cancer	0.0022	0.0048	CcSEcCtD
Cephalexin—Asthenia—Vandetanib—thyroid cancer	0.00215	0.0047	CcSEcCtD
Cephalexin—Arthropathy—Doxorubicin—thyroid cancer	0.00213	0.00465	CcSEcCtD
Cephalexin—Pruritus—Vandetanib—thyroid cancer	0.00212	0.00463	CcSEcCtD
Cephalexin—Arthralgia—Sorafenib—thyroid cancer	0.00211	0.00461	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00209	0.00457	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Epirubicin—thyroid cancer	0.00209	0.00457	CcSEcCtD
Cephalexin—Vaginal inflammation—Epirubicin—thyroid cancer	0.00209	0.00457	CcSEcCtD
Cephalexin—Diarrhoea—Vandetanib—thyroid cancer	0.00205	0.00448	CcSEcCtD
Cephalexin—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00205	0.00447	CcSEcCtD
Cephalexin—Creatinine increased—Doxorubicin—thyroid cancer	0.00203	0.00445	CcSEcCtD
Cephalexin—Anaphylactic shock—Sorafenib—thyroid cancer	0.00202	0.00442	CcSEcCtD
Cephalexin—Colitis—Epirubicin—thyroid cancer	0.00201	0.00439	CcSEcCtD
Cephalexin—Nervous system disorder—Sorafenib—thyroid cancer	0.00198	0.00433	CcSEcCtD
Cephalexin—Dizziness—Vandetanib—thyroid cancer	0.00198	0.00433	CcSEcCtD
Cephalexin—Thrombocytopenia—Sorafenib—thyroid cancer	0.00198	0.00432	CcSEcCtD
Cephalexin—Blood urea increased—Epirubicin—thyroid cancer	0.00198	0.00432	CcSEcCtD
Cephalexin—Vaginal infection—Epirubicin—thyroid cancer	0.00198	0.00432	CcSEcCtD
Cephalexin—Aplastic anaemia—Epirubicin—thyroid cancer	0.00196	0.00429	CcSEcCtD
Cephalexin—Skin disorder—Sorafenib—thyroid cancer	0.00196	0.00429	CcSEcCtD
Cephalexin—Phosphatase alkaline increased—Doxorubicin—thyroid cancer	0.00194	0.00423	CcSEcCtD
Cephalexin—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00194	0.00423	CcSEcCtD
Cephalexin—Vomiting—Vandetanib—thyroid cancer	0.0019	0.00416	CcSEcCtD
Cephalexin—Rash—Vandetanib—thyroid cancer	0.00189	0.00413	CcSEcCtD
Cephalexin—Dermatitis—Vandetanib—thyroid cancer	0.00189	0.00412	CcSEcCtD
Cephalexin—Headache—Vandetanib—thyroid cancer	0.00188	0.0041	CcSEcCtD
Cephalexin—Colitis—Doxorubicin—thyroid cancer	0.00186	0.00406	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00184	0.00402	CcSEcCtD
Cephalexin—Blood urea increased—Doxorubicin—thyroid cancer	0.00183	0.004	CcSEcCtD
Cephalexin—Vaginal infection—Doxorubicin—thyroid cancer	0.00183	0.004	CcSEcCtD
Cephalexin—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00182	0.00397	CcSEcCtD
Cephalexin—Nausea—Vandetanib—thyroid cancer	0.00178	0.00389	CcSEcCtD
Cephalexin—Dyspepsia—Sorafenib—thyroid cancer	0.00178	0.00389	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00175	0.00382	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00174	0.00381	CcSEcCtD
Cephalexin—Fatigue—Sorafenib—thyroid cancer	0.00174	0.00381	CcSEcCtD
Cephalexin—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00174	0.0038	CcSEcCtD
Cephalexin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00165	0.00361	CcSEcCtD
Cephalexin—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00162	0.00353	CcSEcCtD
Cephalexin—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00161	0.00351	CcSEcCtD
Cephalexin—Urticaria—Sorafenib—thyroid cancer	0.00161	0.00351	CcSEcCtD
Cephalexin—Body temperature increased—Sorafenib—thyroid cancer	0.0016	0.00349	CcSEcCtD
Cephalexin—Abdominal pain—Sorafenib—thyroid cancer	0.0016	0.00349	CcSEcCtD
Cephalexin—Osteoarthritis—Epirubicin—thyroid cancer	0.00152	0.00332	CcSEcCtD
Cephalexin—Hypersensitivity—Sorafenib—thyroid cancer	0.00149	0.00325	CcSEcCtD
Cephalexin—Asthenia—Sorafenib—thyroid cancer	0.00145	0.00317	CcSEcCtD
Cephalexin—Pruritus—Sorafenib—thyroid cancer	0.00143	0.00312	CcSEcCtD
Cephalexin—Blood creatinine increased—Epirubicin—thyroid cancer	0.00142	0.00311	CcSEcCtD
Cephalexin—Osteoarthritis—Doxorubicin—thyroid cancer	0.00141	0.00307	CcSEcCtD
Cephalexin—Diarrhoea—Sorafenib—thyroid cancer	0.00138	0.00302	CcSEcCtD
Cephalexin—Breast disorder—Epirubicin—thyroid cancer	0.00137	0.003	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00137	0.00299	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00137	0.00299	CcSEcCtD
Cephalexin—Gastritis—Epirubicin—thyroid cancer	0.00134	0.00294	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00134	0.00293	CcSEcCtD
Cephalexin—Dizziness—Sorafenib—thyroid cancer	0.00134	0.00292	CcSEcCtD
Cephalexin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00132	0.00288	CcSEcCtD
Cephalexin—Eosinophilia—Epirubicin—thyroid cancer	0.0013	0.00284	CcSEcCtD
Cephalexin—Vomiting—Sorafenib—thyroid cancer	0.00128	0.00281	CcSEcCtD
Cephalexin—Rash—Sorafenib—thyroid cancer	0.00127	0.00278	CcSEcCtD
Cephalexin—Dermatitis—Sorafenib—thyroid cancer	0.00127	0.00278	CcSEcCtD
Cephalexin—Breast disorder—Doxorubicin—thyroid cancer	0.00127	0.00278	CcSEcCtD
Cephalexin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00127	0.00277	CcSEcCtD
Cephalexin—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00127	0.00277	CcSEcCtD
Cephalexin—Headache—Sorafenib—thyroid cancer	0.00127	0.00277	CcSEcCtD
Cephalexin—Pancytopenia—Epirubicin—thyroid cancer	0.00125	0.00272	CcSEcCtD
Cephalexin—Gastritis—Doxorubicin—thyroid cancer	0.00124	0.00272	CcSEcCtD
Cephalexin—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00124	0.00271	CcSEcCtD
Cephalexin—Neutropenia—Epirubicin—thyroid cancer	0.00123	0.00268	CcSEcCtD
Cephalexin—Eosinophilia—Doxorubicin—thyroid cancer	0.0012	0.00263	CcSEcCtD
Cephalexin—Nausea—Sorafenib—thyroid cancer	0.0012	0.00262	CcSEcCtD
Cephalexin—Infestation NOS—Epirubicin—thyroid cancer	0.00117	0.00256	CcSEcCtD
Cephalexin—Infestation—Epirubicin—thyroid cancer	0.00117	0.00256	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00116	0.00254	CcSEcCtD
Cephalexin—Pancytopenia—Doxorubicin—thyroid cancer	0.00115	0.00252	CcSEcCtD
Cephalexin—Neutropenia—Doxorubicin—thyroid cancer	0.00114	0.00248	CcSEcCtD
Cephalexin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00111	0.00242	CcSEcCtD
Cephalexin—Agranulocytosis—Epirubicin—thyroid cancer	0.00109	0.00239	CcSEcCtD
Cephalexin—Infestation NOS—Doxorubicin—thyroid cancer	0.00108	0.00237	CcSEcCtD
Cephalexin—Infestation—Doxorubicin—thyroid cancer	0.00108	0.00237	CcSEcCtD
Cephalexin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00107	0.00235	CcSEcCtD
Cephalexin—Haemoglobin—Epirubicin—thyroid cancer	0.00106	0.00231	CcSEcCtD
Cephalexin—Hepatitis—Epirubicin—thyroid cancer	0.00105	0.0023	CcSEcCtD
Cephalexin—Haemorrhage—Epirubicin—thyroid cancer	0.00105	0.0023	CcSEcCtD
Cephalexin—Urinary tract disorder—Epirubicin—thyroid cancer	0.00104	0.00227	CcSEcCtD
Cephalexin—Connective tissue disorder—Epirubicin—thyroid cancer	0.00103	0.00226	CcSEcCtD
Cephalexin—Urethral disorder—Epirubicin—thyroid cancer	0.00103	0.00225	CcSEcCtD
Cephalexin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00102	0.00224	CcSEcCtD
Cephalexin—Agranulocytosis—Doxorubicin—thyroid cancer	0.00101	0.00221	CcSEcCtD
Cephalexin—Erythema multiforme—Epirubicin—thyroid cancer	0.000994	0.00217	CcSEcCtD
Cephalexin—Haemoglobin—Doxorubicin—thyroid cancer	0.000977	0.00214	CcSEcCtD
Cephalexin—Haemorrhage—Doxorubicin—thyroid cancer	0.000972	0.00213	CcSEcCtD
Cephalexin—Hepatitis—Doxorubicin—thyroid cancer	0.000972	0.00213	CcSEcCtD
Cephalexin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00096	0.0021	CcSEcCtD
Cephalexin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000956	0.00209	CcSEcCtD
Cephalexin—Urethral disorder—Doxorubicin—thyroid cancer	0.000953	0.00208	CcSEcCtD
Cephalexin—Immune system disorder—Epirubicin—thyroid cancer	0.000949	0.00207	CcSEcCtD
Cephalexin—Mental disorder—Epirubicin—thyroid cancer	0.000921	0.00201	CcSEcCtD
Cephalexin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000919	0.00201	CcSEcCtD
Cephalexin—Immune system disorder—Doxorubicin—thyroid cancer	0.000878	0.00192	CcSEcCtD
Cephalexin—Mental disorder—Doxorubicin—thyroid cancer	0.000852	0.00186	CcSEcCtD
Cephalexin—Agitation—Epirubicin—thyroid cancer	0.000841	0.00184	CcSEcCtD
Cephalexin—Leukopenia—Epirubicin—thyroid cancer	0.000819	0.00179	CcSEcCtD
Cephalexin—Convulsion—Epirubicin—thyroid cancer	0.000793	0.00173	CcSEcCtD
Cephalexin—Arthralgia—Epirubicin—thyroid cancer	0.000779	0.0017	CcSEcCtD
Cephalexin—Agitation—Doxorubicin—thyroid cancer	0.000778	0.0017	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000774	0.00169	CcSEcCtD
Cephalexin—Leukopenia—Doxorubicin—thyroid cancer	0.000758	0.00166	CcSEcCtD
Cephalexin—Confusional state—Epirubicin—thyroid cancer	0.000753	0.00165	CcSEcCtD
Cephalexin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000747	0.00163	CcSEcCtD
Cephalexin—Convulsion—Doxorubicin—thyroid cancer	0.000733	0.0016	CcSEcCtD
Cephalexin—Nervous system disorder—Epirubicin—thyroid cancer	0.000732	0.0016	CcSEcCtD
Cephalexin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000731	0.0016	CcSEcCtD
Cephalexin—Skin disorder—Epirubicin—thyroid cancer	0.000725	0.00158	CcSEcCtD
Cephalexin—Arthralgia—Doxorubicin—thyroid cancer	0.000721	0.00157	CcSEcCtD
Cephalexin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000716	0.00156	CcSEcCtD
Cephalexin—Confusional state—Doxorubicin—thyroid cancer	0.000697	0.00152	CcSEcCtD
Cephalexin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000691	0.00151	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00068	0.00149	CcSEcCtD
Cephalexin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000678	0.00148	CcSEcCtD
Cephalexin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000676	0.00148	CcSEcCtD
Cephalexin—Skin disorder—Doxorubicin—thyroid cancer	0.000671	0.00147	CcSEcCtD
Cephalexin—Dyspepsia—Epirubicin—thyroid cancer	0.000657	0.00144	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000645	0.00141	CcSEcCtD
Cephalexin—Fatigue—Epirubicin—thyroid cancer	0.000644	0.00141	CcSEcCtD
Cephalexin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000629	0.00138	CcSEcCtD
Cephalexin—Feeling abnormal—Epirubicin—thyroid cancer	0.000615	0.00134	CcSEcCtD
Cephalexin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000611	0.00133	CcSEcCtD
Cephalexin—Dyspepsia—Doxorubicin—thyroid cancer	0.000608	0.00133	CcSEcCtD
Cephalexin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000596	0.0013	CcSEcCtD
Cephalexin—Fatigue—Doxorubicin—thyroid cancer	0.000596	0.0013	CcSEcCtD
Cephalexin—Urticaria—Epirubicin—thyroid cancer	0.000593	0.0013	CcSEcCtD
Cephalexin—Abdominal pain—Epirubicin—thyroid cancer	0.00059	0.00129	CcSEcCtD
Cephalexin—Body temperature increased—Epirubicin—thyroid cancer	0.00059	0.00129	CcSEcCtD
Cephalexin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000569	0.00124	CcSEcCtD
Cephalexin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000565	0.00123	CcSEcCtD
Cephalexin—Hypersensitivity—Epirubicin—thyroid cancer	0.00055	0.0012	CcSEcCtD
Cephalexin—Urticaria—Doxorubicin—thyroid cancer	0.000549	0.0012	CcSEcCtD
Cephalexin—Body temperature increased—Doxorubicin—thyroid cancer	0.000546	0.00119	CcSEcCtD
Cephalexin—Abdominal pain—Doxorubicin—thyroid cancer	0.000546	0.00119	CcSEcCtD
Cephalexin—Asthenia—Epirubicin—thyroid cancer	0.000536	0.00117	CcSEcCtD
Cephalexin—Pruritus—Epirubicin—thyroid cancer	0.000528	0.00115	CcSEcCtD
Cephalexin—Diarrhoea—Epirubicin—thyroid cancer	0.000511	0.00112	CcSEcCtD
Cephalexin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000509	0.00111	CcSEcCtD
Cephalexin—Asthenia—Doxorubicin—thyroid cancer	0.000496	0.00108	CcSEcCtD
Cephalexin—Dizziness—Epirubicin—thyroid cancer	0.000494	0.00108	CcSEcCtD
Cephalexin—Pruritus—Doxorubicin—thyroid cancer	0.000489	0.00107	CcSEcCtD
Cephalexin—Vomiting—Epirubicin—thyroid cancer	0.000475	0.00104	CcSEcCtD
Cephalexin—Diarrhoea—Doxorubicin—thyroid cancer	0.000473	0.00103	CcSEcCtD
Cephalexin—Rash—Epirubicin—thyroid cancer	0.000471	0.00103	CcSEcCtD
Cephalexin—Dermatitis—Epirubicin—thyroid cancer	0.00047	0.00103	CcSEcCtD
Cephalexin—Headache—Epirubicin—thyroid cancer	0.000468	0.00102	CcSEcCtD
Cephalexin—Dizziness—Doxorubicin—thyroid cancer	0.000457	0.000998	CcSEcCtD
Cephalexin—Nausea—Epirubicin—thyroid cancer	0.000444	0.000969	CcSEcCtD
Cephalexin—Vomiting—Doxorubicin—thyroid cancer	0.000439	0.00096	CcSEcCtD
Cephalexin—Rash—Doxorubicin—thyroid cancer	0.000436	0.000952	CcSEcCtD
Cephalexin—Dermatitis—Doxorubicin—thyroid cancer	0.000435	0.000951	CcSEcCtD
Cephalexin—Headache—Doxorubicin—thyroid cancer	0.000433	0.000946	CcSEcCtD
Cephalexin—Nausea—Doxorubicin—thyroid cancer	0.00041	0.000897	CcSEcCtD
